(GLMD) Galmed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Galmed Pharmaceuticals | (GLMD) share price targets
Complete technical analysis of Galmed Pharmaceuticals (GLMD) by charts plus indicators, forecast predictions and share price targets for Galmed Pharmaceuticals (GLMD)
Galmed Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-14 View latest technical analysis
10 day averaged volume of Galmed Pharmaceuticals is 88974
Date | Daily Closing Price | Open | High | Low | Volume |
14 Tue Oct 2025 | 1.44 | 1.47 | 1.50 | 1.37 | 0.995 times |
13 Mon Oct 2025 | 1.47 | 1.43 | 1.47 | 1.41 | 0.46 times |
10 Fri Oct 2025 | 1.42 | 1.53 | 1.60 | 1.41 | 2.452 times |
09 Thu Oct 2025 | 1.56 | 1.53 | 1.61 | 1.53 | 0.629 times |
08 Wed Oct 2025 | 1.55 | 1.57 | 1.60 | 1.55 | 0.394 times |
07 Tue Oct 2025 | 1.58 | 1.65 | 1.65 | 1.52 | 1.748 times |
06 Mon Oct 2025 | 1.61 | 1.55 | 1.61 | 1.53 | 0.868 times |
03 Fri Oct 2025 | 1.57 | 1.60 | 1.63 | 1.54 | 0.72 times |
02 Thu Oct 2025 | 1.57 | 1.50 | 1.61 | 1.50 | 0.401 times |
01 Wed Oct 2025 | 1.55 | 1.43 | 1.55 | 1.39 | 1.859 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.4 as stoploss in an intra day buy trade for a target of 1.49. However, stock will show a bearish move below 1.4.
Share price targets for Galmed Pharmaceuticals (GLMD)
Target Type | Value |
Downside Target | 1.24 |
Downside Target | 1.35 |
Downside Target | 1.41 |
Upside Target | 1.50 |
Upside Target | 1.53 |
Upside Target | 1.60 |
Upside Target | 1.61 |
Upside Target | 1.63 |
Upside Target | 1.65 |
Upside Target | 1.70 |
Upside Target | 1.94 |
Upside Target | 2.34 |
Intraday share price targets for Galmed Pharmaceuticals (GLMD)
Target Type | Value |
Downside Intraday Target | 1.37 |
Downside Intraday Target | 1.31 |
Upside Intraday Target | 1.5 |
Upside Intraday Target | 1.57 |
Downside Intraday Target | 1.44 |
Weekly technical analysis of Galmed Pharmaceuticals (GLMD)
Date | Weekly Closing Price | Open | High | Low | Volume |
14 Tue Oct 2025 | 1.44 | 1.43 | 1.50 | 1.37 | 0.239 times |
10 Fri Oct 2025 | 1.42 | 1.55 | 1.65 | 1.41 | 1.558 times |
03 Fri Oct 2025 | 1.57 | 1.40 | 1.63 | 1.36 | 1.462 times |
26 Fri Sep 2025 | 1.40 | 1.49 | 1.53 | 1.35 | 0.622 times |
19 Fri Sep 2025 | 1.46 | 1.51 | 1.56 | 1.42 | 0.556 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Galmed Pharmaceuticals (GLMD)
Date | Monthly Closing Price | Open | High | Low | Volume |
14 Tue Oct 2025 | 1.44 | 1.43 | 1.65 | 1.37 | 0.551 times |
30 Tue Sep 2025 | 1.38 | 1.26 | 1.60 | 1.24 | 0.342 times |
29 Fri Aug 2025 | 1.27 | 1.61 | 1.70 | 1.26 | 0.611 times |
31 Thu Jul 2025 | 1.63 | 1.83 | 2.34 | 1.61 | 1.253 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Galmed Pharmaceuticals (GLMD)
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Galmed Pharmaceuticals in short term but the sell signal is initial and weak.
Galmed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Galmed Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Galmed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.52 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Galmed Pharmaceuticals ( (GLMD) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Galmed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Galmed Pharmaceuticals in short term but the sell signal is initial and weak.
Galmed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Galmed Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Galmed Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.52 and Galmed Pharmaceuticals (GLMD) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Galmed Pharmaceuticals (GLMD) stock. Volume based technical analysis of Galmed Pharmaceuticals (GLMD) stock is negative.
Galmed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.